AI: DeepSeek (deepseek-chat)

Q: {
  "transcript": "Here’s a fictional but clinically authentic SBAR clerking for a patient with **cervical intraepithelial neoplasia (CIN)**, using British medical terminology and abbreviations:  \n\n---  \n\n### **SBAR CLERKING – CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)**  \n\n#### **SITUATION:**  \n- **Patient:** 32F, G2P1, non-smoker  \n- **Presenting complaint:** Referred to Gynaecology Oncology Clinic following abnormal cervical screening (HPV+ with high-grade dyskaryosis).  \n- **Key issue:** Colposcopy-confirmed **CIN3** (squamo-columnar junction fully visible, satisfactory colposcopy). Asymptomatic, no PV bleeding/discharge.  \n\n#### **BACKGROUND:**  \n- **PMHx:** Previous LLETZ (2019) for CIN2. No other gynae history.  \n- **Obstetric Hx:** SVD 2018 (no complications).  \n- **Medications:** Nil regular. No allergies.  \n- **Risk factors:** Persistent high-risk HPV (type 16 detected), previous CIN.  \n- **Last menstrual period (LMP):** Day 12 of cycle.  \n\n#### **ASSESSMENT:**  \n- **Observations:** Afebrile, BP 118/72, HR 72, BMI 24.  \n- **Examination:** Speculum – healthy cervix, no contact bleeding. No vulval/vaginal lesions.  \n- **Colposcopy findings:** Acetowhite epithelium, coarse mosaicism, punctation at 3 o’clock (TZ3).  \n- **Histology (biopsy):** CIN3 with clear margins. No invasive features.  \n- **Recent investigations:**  \n  - **HPV PCR:** Positive (type 16).  \n  - **FBC:** Normal (Hb 132, WBC 6.2, Plt 280).  \n  - **USS pelvis:** Normal uterus/adnexa.  \n\n#### **RECOMMENDATION:**  \n1. **Treatment:**  \n   - **LLETZ excision** under local anaesthesia (GA if anxious) – booked for next available list.  \n   - Consent for possible future preterm labour risk (cervical weakness).  \n\n2. **Follow-up:**  \n   - **Post-op HPV test at 6 months** (if negative, return to routine screening; if positive, repeat colposcopy).  \n   - **Annual cytology x3 years** if margins unclear on histology.  \n\n3. **Patient counselling:**  \n   - Reinforce HPV vaccination (if not already received).  \n   - Advise barrier contraception to reduce HPV transmission risk.  \n   - Safety-netting: Report PV bleeding/pelvic pain.  \n\n4. **MDT referral:**  \n   - Discuss in **Gynae-Oncology MDT** if any suspicion of microinvasion on histology.  \n\n---  \n\n**Notes:**  \n- Follows **BSCCP/British Gynaecological Cancer Society** guidelines.  \n- Fictional for educational purposes.  \n\nWould you like any modifications (e.g., more detail on histology, MDT criteria, or patient counselling points)?",
  "guidelinesCount": 266,
  "chunksProcessed": 34,
  "chunksFailed": 0
}

A: {
  "success": true,
  "categoriesFound": 266,
  "mostRelevantCount": 2,
  "potentiallyRelevantCount": 10,
  "lessRelevantCount": 38,
  "notRelevantCount": 216
}